Mosaic ImmunoEngineering Inc. financial data

Symbol
CPMV on OTC
Location
9114 Adams Ave., #202, Huntington Beach, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
PATRIOT SCIENTIFIC CORP (to 11/19/2020)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.88 % -61.9%
Debt-to-equity -102 % +3.6%
Return On Equity 20.1 % -6.72%
Return On Assets -871 % -147%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.24M shares 0%
Common Stock, Shares, Outstanding 7.24M shares 0%
Entity Public Float 817K USD -44.4%
Common Stock, Value, Issued 72 USD 0%
Weighted Average Number of Shares Outstanding, Basic 7.24M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 7.24M shares -15.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 263K USD -63.4%
General and Administrative Expense 868K USD -21.7%
Operating Income (Loss) -1.13M USD +38.1%
Nonoperating Income (Expense) -80.5K USD -111%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.21M USD -13.7%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -1.21M USD -13.5%
Earnings Per Share, Basic -0.16 USD/shares -6.67%
Earnings Per Share, Diluted -0.16 USD/shares -6.67%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.73K USD -99%
Assets, Current 12.3K USD -96.7%
Assets 12.3K USD -96.7%
Accounts Payable, Current 125K USD -4.61%
Employee-related Liabilities, Current 3.51M USD +24.3%
Accrued Liabilities, Current 624K USD +5.94%
Liabilities, Current 5.11M USD +17.5%
Liabilities 6.46M USD +14.9%
Retained Earnings (Accumulated Deficit) -8.5M USD -16.6%
Stockholders' Equity Attributable to Parent -6.45M USD -22.7%
Liabilities and Equity 12.3K USD -96.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -91.1K USD +47%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 7.24M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.73K USD -99%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 3.15M USD +11.5%
Deferred Tax Assets, Operating Loss Carryforwards 442K USD -12.4%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 2.05M USD +0.78%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 4.87K USD -10%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%